ANEB vs COO · $15.3M cap vs P/E 36, rev $4.09B
Anebulo Pharmaceuticals Inc (ANEB) versus The Cooper Companies, Inc (COO) — a side-by-side from cached financials, not a winner call.
Anebulo Pharmaceuticals Inc (ANEB) is a biotechnology company listed on US.
The Cooper Companies, Inc (COO) is a medical instruments & supplies company listed on US.
ANEB does not have a complete income-statement cache yet.
Latest reported COO revenue for 2025-10-31 was $4.09B. Net income was $374.9M. COO currently screens at market cap $14.92B and trailing P/E 36.1.
ANEB currently screens at market cap $15.3M. COO currently screens at market cap $14.92B and trailing P/E 36.1.
Not investment advice. Open the ANEB and COO stock pages for the full models.
Not investment advice.